![Limor Zur-Stoller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Limor Zur-Stoller
Geen lopende functies
Loopbaan van Limor Zur-Stoller
Eerdere bekende functies van Limor Zur-Stoller
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ROSETTA GENOMICS LTD. | Financieel Directeur/CFO | 06-11-2009 | 01-10-2010 |
G.F.C GREEN FIELDS CAPITAL LTD. | Financieel Directeur/CFO | 19-04-2011 | - |
Public Communications Contact | 19-04-2011 | - | |
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Directeur/Bestuurslid | 26-04-2011 | - |
Financieel Directeur/CFO | 19-03-2008 | - | |
Treasurer | 19-03-2008 | - | |
RADVIEW SOFTWARE LTD. | Financieel Directeur/CFO | - | - |
Public Communications Contact | 29-06-2009 | - |
Opleiding van Limor Zur-Stoller
Tel-Aviv University | Undergraduate Degree |
Statistieken
Internationaal
Israël | 6 |
Operationeel
Director of Finance/CFO | 4 |
Public Communications Contact | 2 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Technology Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
RADVIEW SOFTWARE LTD. | Technology Services |
ROSETTA GENOMICS LTD. | Health Technology |
G.F.C GREEN FIELDS CAPITAL LTD. | Finance |
Bedrijven in privébezit | 1 |
---|---|
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Beurs
- Insiders
- Limor Zur-Stoller
- Ervaring